US STOCK
GH Stock Analysis
US stocks · market data · technical indicators
Guardant Health, Inc.
GHUS stocksQuote delayed 15 min
10/27 上午01:25 updated
$174.62
+5.53+3.27%
Open
$170.10
High
$175.03
Low
$168.73
Volume
83.84萬
GH price history
-1.53%Open
177.33
Latest
174.62
High
187.22
Low
157.88
Average
169.11
Advertisement
Financial snapshot
GH - Guardant Health, Inc.
EPS
-3.50USD
Forward EPS
-0.38USD
P/E
--
Forward P/E
-460.44x
P/B
-104.67x
ROE
--
ROA
-18.07%
Operating margin
-38.25%
Profit margin
-38.33%
Revenue growth
44.30%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $334.98M | $301.67M | $281.27M | $265.20M | $232.09M |
| Gross profit | $219.03M | $196.75M | $181.77M | $171.61M | $150.88M |
| Operating income | -$129.12M | -$121.35M | -$120.81M | -$98.99M | -$106.41M |
| Net income | -$120.14M | -$112.08M | -$128.49M | -$92.72M | -$99.90M |
| Basic EPS | -0.90 | -0.85 | -1.00 | -0.74 | -0.80 |
| Diluted EPS | -0.90 | -0.85 | -1.00 | -0.74 | -0.80 |
Estimates vs actuals
Next earnings
2026-11-05
EPS estimate
-0.31
Revenue estimate
$350.73M
Last surprise
-7.81%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-11-05 | -0.31 | Not reported | — |
| 2026-07-30 | -0.39 | -0.42 | -7.81% |
| 2026-05-07 | -0.47 | -0.45 | +4.97% |
| 2026-02-19 | -0.47 | -0.50 | -6.51% |
| 2025-10-29 | -0.49 | -0.39 | +20.33% |
| 2025-07-30 | -0.51 | -0.44 | +14.54% |
| 2025-04-30 | -0.59 | -0.49 | +17.00% |
| 2025-02-20 | -0.50 | -0.62 | -23.05% |
| 2024-11-06 | -0.60 | -0.45 | +24.38% |
| 2024-08-07 | -0.61 | -0.48 | +21.02% |
| 2024-05-09 | -0.73 | -0.46 | +37.01% |
| 2024-02-22 | -0.75 | -0.64 | +14.24% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $1.2B | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $558M | 0.40% |
| STATE STREET CORP | 2026-06-30 | $339.6M | 0.01% |
| BlackRock Inc. | 2024-06-30 | $324.5M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $217.5M | 0.02% |
| Bridgewater Associates, LP | 2026-06-30 | $636.7K | 0.00% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$201.64
Target range
$105.00 – $240.00
Implied upside
15.50%
Strong buy
4
Buy
21
Hold
0
Sell
0
Strong sell
1
Advertisement